What is the current Price Target for the Lyell Immunopharma Inc stock?

The average Lyell Immunopharma Inc target price is $0.80. This is 82.44% higher than the current stock price. The highest price target is 128.05%, the lowest is 36.83%. 2 Analysts have issued a price target Lyell Immunopharma Inc 2026 .

How high will the Lyell Immunopharma Inc stock rise?

No reliable answer can be given as to how high the Lyell Immunopharma Inc stock will rise. The performance of stocks, including the Lyell Immunopharma Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Lyell Immunopharma Inc stock today?

The performance of Lyell Immunopharma Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Lyell Immunopharma Inc stock fall?

The decline in Lyell Immunopharma Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Lyell Immunopharma Inc Forecast, price target & analysts

$0.42

0.63% yesterday

Nasdaq, Apr 11, 09:49 pm CET

ISIN

US55083R1041

Symbol

LYEL

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Lyell Immunopharma Inc Target price 2025 - Analyst rating & recommendation

Lyell Immunopharma Inc Classifications & Recommendation:

Hold

67%

Sell

33%

Lyell Immunopharma Inc Price Target

Target Price	$0.80
Price	$0.44
Potential	82.44% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Lyell Immunopharma Inc 2026 . The average Lyell Immunopharma Inc target price is $0.80. This is 82.44% register free of charge higher than the current stock price. The highest price target is $1.00 128.05% register free of charge , the lowest is $0.60 36.83% register free of charge .
	A rating was issued by 3 analysts: 0 Analysts recommend Lyell Immunopharma Inc to buy, 2 to hold and 1 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Lyell Immunopharma Inc stock has an average upside potential 2026 of 82.44% register free of charge . Most analysts recommend the Lyell Immunopharma Inc stock at Hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.31	-0.76
	40.86%	41.98%
P/E		negative

2 Analysts have issued a Lyell Immunopharma Inc forecast for earnings per share. The average Lyell Immunopharma Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.31	40.86%
2025	$-0.76 41.98% Unlock
2026	$-0.80 5.26% Unlock
2027	$-0.88 10.00% Unlock

Current	-0.33	85.27%
2025	-0.58 75.76% Unlock
2026	-0.55 5.17% Unlock
2027	-0.50 9.09% Unlock

Lyell Immunopharma Inc...

Current Lyell Immunopharma Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 13 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 12 2024
B of A Securities	Locked ➜ Locked	Locked	Oct 30 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 28 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 19 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 13 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 12 2024
Locked B of A Securities: Locked ➜ Locked	Oct 30 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 28 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 19 2024

Discover more stocks with a high price target

Novo Nordisk 85.76%

MongoDB 77.37%

TUI 71.12%

Coinbase Global, Inc. 63.83%

Infineon 61.01%

Alibaba Group Holding Ltd 55.02%

BioNTech SE - ADR 45.05%

Snowflake 42.40%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now